160 related articles for article (PubMed ID: 37768027)
1. Clinical characteristics and risk factors of acute lymphoblastic leukemia in children with severe infection during maintenance treatment.
Yin T; Han J; Hao J; Yu H; Qiu Y; Xu J; Peng Y; Wu X; Jin R; Zhou F
Cancer Med; 2023 Oct; 12(19):19372-19382. PubMed ID: 37768027
[TBL] [Abstract][Full Text] [Related]
2. PROGNOSIS OF THE COURSE OF CHORNOBYL-ORIGINATED ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN IN UKRAINE DEPENDING ON THE REASON OF STANDARD CHEMOTHERAPY INTERRUPTION.
Bebeshko VG; Bruslova KM; Tsvetkova NM; Lyashenko LO; Pushkariova TI; Gonchar LO; Tryhlib IV; Yatsemirskyi SM; Samson YM; Boyarskyi VG; Grischenko KV; Polyanska VM; Dmytrenko IV
Probl Radiac Med Radiobiol; 2019 Dec; 24():335-349. PubMed ID: 31841478
[TBL] [Abstract][Full Text] [Related]
3. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.
Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ
J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371
[TBL] [Abstract][Full Text] [Related]
4. Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Locatelli F; Zugmaier G; Rizzari C; Morris JD; Gruhn B; Klingebiel T; Parasole R; Linderkamp C; Flotho C; Petit A; Micalizzi C; Mergen N; Mohammad A; Kormany WN; Eckert C; Möricke A; Sartor M; Hrusak O; Peters C; Saha V; Vinti L; von Stackelberg A
JAMA; 2021 Mar; 325(9):843-854. PubMed ID: 33651091
[TBL] [Abstract][Full Text] [Related]
5. Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Brown PA; Ji L; Xu X; Devidas M; Hogan LE; Borowitz MJ; Raetz EA; Zugmaier G; Sharon E; Bernhardt MB; Terezakis SA; Gore L; Whitlock JA; Pulsipher MA; Hunger SP; Loh ML
JAMA; 2021 Mar; 325(9):833-842. PubMed ID: 33651090
[TBL] [Abstract][Full Text] [Related]
6. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group.
Sato A; Hatta Y; Imai C; Oshima K; Okamoto Y; Deguchi T; Hashii Y; Fukushima T; Hori T; Kiyokawa N; Kato M; Saito S; Anami K; Sakamoto T; Kosaka Y; Suenobu S; Imamura T; Kada A; Saito AM; Manabe A; Kiyoi H; Matsumura I; Koh K; Watanabe A; Miyazaki Y; Horibe K
Lancet Haematol; 2023 Jun; 10(6):e419-e432. PubMed ID: 37167992
[TBL] [Abstract][Full Text] [Related]
7. Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma--a rationale for tailored supportive care.
Lex C; Körholz D; Kohlmüller B; Bönig H; Willers R; Kramm CM; Göbel U
Support Care Cancer; 2001 Oct; 9(7):514-21. PubMed ID: 11680831
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA
Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245
[TBL] [Abstract][Full Text] [Related]
9. Cryptosporidiosis in children with acute lymphoblastic leukemia on maintenance chemotherapy.
Domenech C; Rabodonirina M; Bleyzac N; Pagès MP; Bertrand Y
J Pediatr Hematol Oncol; 2011 Oct; 33(7):570-2. PubMed ID: 21941152
[TBL] [Abstract][Full Text] [Related]
10. Necrotizing fasciitis in two children with acute lymphoblastic leukemia.
Duncan BW; Adzick NS; deLorimier AA; Longaker MT; Ferrell LD; Zoger S; Harrison MR
J Pediatr Surg; 1992 May; 27(5):668-71. PubMed ID: 1625147
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic difficulties of AH1N1 influenza infection in children with acute lymphoblastic leukemia: Two case reports.
Zawitkowska J; Lejman M; Drabko K; Zaucha-Prażmo A
Medicine (Baltimore); 2020 Oct; 99(43):e22790. PubMed ID: 33120795
[TBL] [Abstract][Full Text] [Related]
12. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience.
Li MJ; Chang HH; Yang YL; Lu MY; Shao PL; Fu CM; Chou AK; Liu YL; Lin KH; Huang LM; Lin DT; Jou ST
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371256
[TBL] [Abstract][Full Text] [Related]
13. Infection-related complications during treatment for childhood acute lymphoblastic leukemia.
Inaba H; Pei D; Wolf J; Howard SC; Hayden RT; Go M; Varechtchouk O; Hahn T; Buaboonnam J; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Evans WE; Relling MV; Pui CH
Ann Oncol; 2017 Feb; 28(2):386-392. PubMed ID: 28426102
[TBL] [Abstract][Full Text] [Related]
14. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
Vora A; Goulden N; Wade R; Mitchell C; Hancock J; Hough R; Rowntree C; Richards S
Lancet Oncol; 2013 Mar; 14(3):199-209. PubMed ID: 23395119
[TBL] [Abstract][Full Text] [Related]
15. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
[TBL] [Abstract][Full Text] [Related]
16. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
Abdelrazik N; Fouda M
Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemia.
Rosenfeld E; Getz KD; Miller TP; Seif AE; Fisher BT; Burrows E; Ramos MJ; De León DD; Aplenc R; Morales KH; Guevara JP
Pediatr Blood Cancer; 2022 Jun; 69(6):e29467. PubMed ID: 34811879
[TBL] [Abstract][Full Text] [Related]
18. Obesity in pediatric patients with acute lymphoblastic leukemia increases the risk of adverse events during pre-maintenance chemotherapy.
Meenan CK; Kelly JA; Wang L; Ritchey AK; Maurer SH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27515. PubMed ID: 30362242
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of 3 cases of mucormycosis in children with acute lymphoblastic leukemia and literature review].
Sun HY; Li B; Liu Y; You HL; Liu YF
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):56-61. PubMed ID: 34986625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
